Scotts’ Hawthorne marijuana grow sales plummet 63% in latest financial quarter

Be at the forefront of cannabis and psychedelics science and innovation. Register by March 14 & Save $100 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.

Scotts Miracle-Gro’s Hawthorne unit took another big hit in the company’s fiscal quarter ended July 2 because of continued oversupply in the softening marijuana industry.

The Ohio-based lawn and gardening giant reported that Hawthorne sales fell 63% to $154.5 million, compared with $421.9 million during the same period last year.

Company sales overall decreased by 26%, driven by the decline in Hawthorne Gardening Co., which provides cannabis cultivation supplies.

As a result, Scotts Miracle-Gro announced “Project Springboard,” an endeavor to strengthen its balance sheet and improve cash flow.

“The lower-than-expected sales in our U.S. consumer segment, combined with continued pressure on Hawthorne sales due to oversupply issues in the cannabis industry, leave us unsatisfied with our financial results and with higher leverage than we want to maintain,” Scotts Chair and CEO Jim Hagedorn said in a news release.

“That is why we have launched the business transformation effort we are calling Project Springboard, which includes a series of aggressive steps to return the business to an appropriate level of performance.”

Business leaders need reliable industry data and in-depth analysis to make smart investments and informed decisions in these uncertain economic times.

Get your 2023 MJBiz Factbook now!

Featured Inside:
  • 200+ pages and 50 charts with key data points
  • State-by-state guide to regulations, taxes & opportunities
  • Segmented research reports for the marijuana + hemp industries
  • Accurate financial forecasts + investment trends


Stay ahead of the curve and avoid costly missteps in the rapidly evolving cannabis industry.

In early May, Scotts expressed confidence that Hawthorne’s sales were beginning to firm, but the subsidiary then experienced another sharp decline because of a cannabis industry slowdown, oversupply and increased costs.

Despite the poor sales performance, Hawthorne has been on a buying binge that includes a $215 million acquisition of Los Angeles-based Luxx Lighting cannabis grow systems as well as a research and development facility in Canada.